What is Bortezomib-doxorubicin-dexamethasone (PAD)?

Category: Prescription Drugs

false

See also: Bortezomib Doxorubicin

Bortezomib-doxorubicin-dexamethasone, also known as PAD, is a regimen that may be used for the treatment of multiple myeloma. It contains the anticancer agents bortezomib and doxorubicin along with dexamethasone, a corticosteroid.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 1
None 0

Commonly reported side effects and conditions associated with Bortezomib-doxorubicin-dexamethasone (PAD)

Side effect Patients
Bone pain 1

Duration

Currently taking Bortezomib-doxorubicin-dexamethasone (PAD)

Duration Patients
10 years or more 1
Adherence
Adherence Evaluations
Always 1
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 1
Last updated:
There are no evaluations for Bortezomib-doxorubicin-dexamethasone (PAD).